Article: Levitra(R) (vardenafil HCl) to Launch in Europe this Month as Newest Treatment Option for Erectile Dysfunction; -- New Flexible-Dose Study Shows Significant Improvement in Erections Among Men Taking LEVITRA --.

WEST HAVEN, Conn. and PHILADELPHIA -- WEST HAVEN, Conn. and PHILADELPHIA, March 13 /PRNewswire/ -- Bayer Pharmaceuticals Corporation and GlaxoSmithKline announced today the European launch and availability of Levitra(R) (vardenafil HCl) in many European markets at the 18th Congress of the European Association of Urology (EAU) in Madrid. LEVITRA is the newest oral treatment for the improvement of erectile function (EF) in men with erectile dysfunction (ED). The announcement comes days after the two companies received marketing authorization for LEVITRA from the European Commission. In the United States, the Food and Drug Administration (FDA) issued an approvable letter ...






Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!